Hypertension and cognitive dysfunction in elderly

Blood pressure management for this global burden

Marijana Tadic, Cesare Cuspidi, Dagmara Hering

Research output: Contribution to journalReview article

32 Citations (Scopus)

Abstract

Arterial hypertension and stroke are strong independent risk factors for the development of cognitive impairment and dementia. Persistently elevated blood pressure (BP) is known to impair cognitive function, however onset of new cognitive decline is common following a large and multiple mini strokes. Among various forms of dementia the most prevalent include Alzheimer's disease (AD) and vascular dementia (VaD) which often present with similar clinical symptoms and challenging diagnosis. While hypertension is the most important modifiable vascular risk factor with antihypertensive therapy reducing the risk of stroke and potentially slowing cognitive decline, optimal BP levels for maintaining an ideal age-related mental performance are yet to be established. Cognition has improved following the use of at least one representative agent of the major drug classes with further neuroprotection with renin angiotensin inhibitors and calcium channel blockers in the hypertensive elderly. However, a reduction in BP may worsen cerebral perfusion causing an increased risk of CV complications due to the J-curve phenomenon. Given the uncertainties and conflicting results from randomized trials regarding the hypertension management in the elderly, particularly octogenarians, antihypertensive approaches are primarily based on expert opinion. Herein, we summarize available data linking arterial hypertension to cognitive decline and antihypertensive approach with potential benefits in improving cognitive function in elderly hypertensive patients.

Original languageEnglish
Article number208
JournalBMC Cardiovascular Disorders
Volume16
Issue number1
DOIs
Publication statusPublished - Nov 3 2016

Fingerprint

Cognition
Antihypertensive Agents
Blood Pressure
Hypertension
Stroke
Dementia
Alzheimer Disease
Vascular Dementia
Angiotensins
Calcium Channel Blockers
Expert Testimony
Renin
Uncertainty
Perfusion
Cognitive Dysfunction
Pharmaceutical Preparations
Therapeutics
vascular factor
Neuroprotection

Keywords

  • Antihypertensive therapy
  • Arterial hypertension
  • Cognitive decline
  • Dementia

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hypertension and cognitive dysfunction in elderly : Blood pressure management for this global burden. / Tadic, Marijana; Cuspidi, Cesare; Hering, Dagmara.

In: BMC Cardiovascular Disorders, Vol. 16, No. 1, 208, 03.11.2016.

Research output: Contribution to journalReview article

@article{fd6415459d044a4bb17e011269e98285,
title = "Hypertension and cognitive dysfunction in elderly: Blood pressure management for this global burden",
abstract = "Arterial hypertension and stroke are strong independent risk factors for the development of cognitive impairment and dementia. Persistently elevated blood pressure (BP) is known to impair cognitive function, however onset of new cognitive decline is common following a large and multiple mini strokes. Among various forms of dementia the most prevalent include Alzheimer's disease (AD) and vascular dementia (VaD) which often present with similar clinical symptoms and challenging diagnosis. While hypertension is the most important modifiable vascular risk factor with antihypertensive therapy reducing the risk of stroke and potentially slowing cognitive decline, optimal BP levels for maintaining an ideal age-related mental performance are yet to be established. Cognition has improved following the use of at least one representative agent of the major drug classes with further neuroprotection with renin angiotensin inhibitors and calcium channel blockers in the hypertensive elderly. However, a reduction in BP may worsen cerebral perfusion causing an increased risk of CV complications due to the J-curve phenomenon. Given the uncertainties and conflicting results from randomized trials regarding the hypertension management in the elderly, particularly octogenarians, antihypertensive approaches are primarily based on expert opinion. Herein, we summarize available data linking arterial hypertension to cognitive decline and antihypertensive approach with potential benefits in improving cognitive function in elderly hypertensive patients.",
keywords = "Antihypertensive therapy, Arterial hypertension, Cognitive decline, Dementia",
author = "Marijana Tadic and Cesare Cuspidi and Dagmara Hering",
year = "2016",
month = "11",
day = "3",
doi = "10.1186/s12872-016-0386-0",
language = "English",
volume = "16",
journal = "BMC Cardiovascular Disorders",
issn = "1471-2261",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Hypertension and cognitive dysfunction in elderly

T2 - Blood pressure management for this global burden

AU - Tadic, Marijana

AU - Cuspidi, Cesare

AU - Hering, Dagmara

PY - 2016/11/3

Y1 - 2016/11/3

N2 - Arterial hypertension and stroke are strong independent risk factors for the development of cognitive impairment and dementia. Persistently elevated blood pressure (BP) is known to impair cognitive function, however onset of new cognitive decline is common following a large and multiple mini strokes. Among various forms of dementia the most prevalent include Alzheimer's disease (AD) and vascular dementia (VaD) which often present with similar clinical symptoms and challenging diagnosis. While hypertension is the most important modifiable vascular risk factor with antihypertensive therapy reducing the risk of stroke and potentially slowing cognitive decline, optimal BP levels for maintaining an ideal age-related mental performance are yet to be established. Cognition has improved following the use of at least one representative agent of the major drug classes with further neuroprotection with renin angiotensin inhibitors and calcium channel blockers in the hypertensive elderly. However, a reduction in BP may worsen cerebral perfusion causing an increased risk of CV complications due to the J-curve phenomenon. Given the uncertainties and conflicting results from randomized trials regarding the hypertension management in the elderly, particularly octogenarians, antihypertensive approaches are primarily based on expert opinion. Herein, we summarize available data linking arterial hypertension to cognitive decline and antihypertensive approach with potential benefits in improving cognitive function in elderly hypertensive patients.

AB - Arterial hypertension and stroke are strong independent risk factors for the development of cognitive impairment and dementia. Persistently elevated blood pressure (BP) is known to impair cognitive function, however onset of new cognitive decline is common following a large and multiple mini strokes. Among various forms of dementia the most prevalent include Alzheimer's disease (AD) and vascular dementia (VaD) which often present with similar clinical symptoms and challenging diagnosis. While hypertension is the most important modifiable vascular risk factor with antihypertensive therapy reducing the risk of stroke and potentially slowing cognitive decline, optimal BP levels for maintaining an ideal age-related mental performance are yet to be established. Cognition has improved following the use of at least one representative agent of the major drug classes with further neuroprotection with renin angiotensin inhibitors and calcium channel blockers in the hypertensive elderly. However, a reduction in BP may worsen cerebral perfusion causing an increased risk of CV complications due to the J-curve phenomenon. Given the uncertainties and conflicting results from randomized trials regarding the hypertension management in the elderly, particularly octogenarians, antihypertensive approaches are primarily based on expert opinion. Herein, we summarize available data linking arterial hypertension to cognitive decline and antihypertensive approach with potential benefits in improving cognitive function in elderly hypertensive patients.

KW - Antihypertensive therapy

KW - Arterial hypertension

KW - Cognitive decline

KW - Dementia

UR - http://www.scopus.com/inward/record.url?scp=84998887096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84998887096&partnerID=8YFLogxK

U2 - 10.1186/s12872-016-0386-0

DO - 10.1186/s12872-016-0386-0

M3 - Review article

VL - 16

JO - BMC Cardiovascular Disorders

JF - BMC Cardiovascular Disorders

SN - 1471-2261

IS - 1

M1 - 208

ER -